Suppr超能文献

羟氯喹治疗后出现的精神运动性激越。

Psychomotor Agitation Following Treatment with Hydroxychloroquine.

作者信息

Manzo Ciro, Gareri Pietro, Castagna Alberto

机构信息

Internal and geriatric department, Rheumatologic outpatient clinic and geronthorheumatologic service, Hospital "Mariano Lauro", viale dei Pini 1, 80065, Sant'Agnello, Naples, Italy.

Center for cognitive diseases and dementias, Catanzaro Lido, ASP Catanzaro, Catanzaro, Italy.

出版信息

Drug Saf Case Rep. 2017 Dec;4(1):6. doi: 10.1007/s40800-017-0048-x.

Abstract

We describe the case of an elderly woman with elderly-onset rheumatoid arthritis, where the use of 4 mg/kg/day of hydroxychloroquine (HCQ) was followed by the onset of psychomotor agitation with marked physical and verbal violence towards her partner, including throwing objects at her partner. No disturbance in sleep and no anxiety, nervousness, or irritability had emerged before the onset of her psychomotor agitation. The disappearance of agitation following targeted pharmacologic intervention and HCQ interruption, its re-onset after reintroduction of the drug, and the high score (9) of Naranjo's algorithm are surely linked to the existence of a causal relationship between HCQ and psychomotor agitation. HCQ may produce undesirable effects on the central nervous system, mainly irritability, nervousness, emotional changes, and nightmares. To the best of our knowledge, there are only a few case reports of psychosis due to HCQ. No favoring condition such as pharmacokinetic interactions or a personal and family psychiatric history was present in our patient. The neuropsychiatric manifestations we observed could be considered a bizarre-type adverse drug reaction linked to an individual's hypersensitivity.

摘要

我们描述了一位患有老年发病型类风湿性关节炎的老年女性病例,在使用4毫克/千克/天的羟氯喹(HCQ)后,出现了精神运动性激越,并对其伴侣表现出明显的身体暴力和言语暴力,包括向伴侣扔东西。在她的精神运动性激越发作之前,没有出现睡眠障碍、焦虑、紧张或易怒的情况。针对性药物干预和停用HCQ后激越消失,重新用药后激越再次出现,以及Naranjo算法的高分(9分)肯定与HCQ和精神运动性激越之间存在因果关系有关。HCQ可能会对中枢神经系统产生不良影响,主要是易怒、紧张、情绪变化和噩梦。据我们所知,仅有少数因HCQ导致精神病的病例报告。我们的患者不存在诸如药代动力学相互作用或个人及家族精神病史等有利因素。我们观察到的神经精神表现可被视为与个体超敏反应相关的怪异型药物不良反应。

相似文献

引用本文的文献

2
Safety of Hydroxychloroquine: What a Dermatologist Should Know.羟氯喹的安全性:皮肤科医生应了解的内容。
Am J Clin Dermatol. 2025 Mar;26(2):251-264. doi: 10.1007/s40257-025-00919-x. Epub 2025 Feb 3.
8
Phthalimide analogs for antimalarial drug discovery.用于抗疟药物研发的邻苯二甲酰亚胺类似物。
RSC Med Chem. 2021 Aug 13;12(11):1854-1867. doi: 10.1039/d1md00244a. eCollection 2021 Nov 17.
9
Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19.使用羟氯喹治疗2019冠状病毒病患者的风险与益处
Can J Infect Dis Med Microbiol. 2021 Sep 15;2021:5942366. doi: 10.1155/2021/5942366. eCollection 2021.
10
Subclinical myopathic changes in COVID-19.COVID-19 中的亚临床肌病变化。
Neurol Sci. 2021 Oct;42(10):3973-3979. doi: 10.1007/s10072-021-05469-8. Epub 2021 Jul 25.

本文引用的文献

3
Neuropsychiatric manifestations in rheumatoid arthritis.类风湿关节炎的神经精神表现。
Autoimmun Rev. 2015 Dec;14(12):1116-22. doi: 10.1016/j.autrev.2015.07.015. Epub 2015 Jul 31.
6
Psychiatric symptoms induced by hydroxychloroquine.羟氯喹诱导的精神症状。
Lupus. 2015 Mar;24(3):339-40. doi: 10.1177/0961203314558863. Epub 2014 Nov 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验